Print Page  Close Window

Press Releases

Keyword Search
 
Current | Archive
DateTitle 
08/04/15OraSure Technologies to Present at the Canaccord Genuity 35th Annual Growth Conference
BETHLEHEM, Pa., Aug. 4, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 35th Annual Growth Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak August 12, 2015, at approximately 2:00 PM Eastern ... 
Printer Friendly Version
08/03/15Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test
BETHLEHEM, Pa., Aug. 3, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its OraQuick® Ebola Rapid Antigen Test for use with fingerstick and venous whole blood. This test has not been cleared or approved by FDA. This test has been authorized by FDA under an EUA for use by laboratories... 
Printer Friendly Version
07/15/15OraSure Technologies Earnings Conference Call Invitation
2015 Second Quarter Earnings Conference Call Wednesday, August 5, 2015, 5:00 p.m. ET BETHLEHEM, Pa., July 15, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2015 second quarter financial results, 2015 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 5, 2015. August 5, 2015 Schedule       ... 
Printer Friendly Version
07/07/15DNA Genotek Inc. Receives CE-IVD Mark for its OMNIgene®•GUT Microbiome Collection Kit
OTTAWA, ON, July 7, 2015. DNA Genotek, a leading provider of sample collection kits and end-to-end services and a subsidiary of OraSure Technologies, Inc. (Nasdaq: OSUR) today announced that its OMNIgene®•GUT microbiome collection kit has received CE-IVD marking through completion of a comprehensive technical validation and self declaration under the European Directive for In Vitro Diagnostic Medical Devices.The CE-IVD marked OMNIgene•GUT is an all-in-one system designed to enable an individual ... 
Printer Friendly Version
06/26/15OraSure Supports Rapid HIV Testing Initiatives in Recognition of National HIV Testing Day
Company Teams With The D.I.V.A. Foundation, Greater Than AIDS and Other Community Voices to Promote HIV Testing With OraQuick(R) BETHLEHEM, Pa., June 26, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced its support of various rapid HIV testing initiatives and events taking place this week in recognition of the 20th Anniversary of National HIV Testing Day, held each year on June 27th. Th... 
Printer Friendly Version
06/16/15OraSure Technologies to Present at the 2015 JMP Securities Life Sciences Conference
BETHLEHEM, Pa., June 16, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2015 JMP Securities Life Sciences Conference in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak June 23, 2015, at approximately 10:00 AM Eastern Time (7:00 AM Pacific Time). Interested investors can access the live webcast of the presenta... 
Printer Friendly Version
06/12/15OraSure Awarded $10.4 Million HHS Contract to Advance Rapid Ebola Test Clinical Development
BETHLEHEM, Pa., June 12, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has been awarded a contract for up to $10.4 million in total funding from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response's Biomedical Advanced Research and Development Authority (BARDA) related to the Company's OraQuick® Ebola Rapid Ant... 
Printer Friendly Version
05/22/15Orasure Technologies to Present at the Jefferies 2015 Global Healthcare Conference
BETHLEHEM, Pa., May 22, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2015 Global Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak June 2, 2015, at approximately 10:00 AM Eastern Time (7:00 AM Pacific Time). Interested investors can access the live webcast of the presentatio... 
Printer Friendly Version
05/19/15OraSure Technologies Supports Rapid HCV Testing Initiatives Across the U.S. in Recognition of National Hepatitis Testing Day
BETHLEHEM, Pa., May 19, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced its support of numerous rapid hepatitis C (HCV) testing events for National Hepatitis Testing Day, taking place on May 19, 2015. These testing initiatives, happening across the country, will help encourage thousands of people across the U.S. to get tested for hepatitis C with the OraQuick® HCV rapid test. Nation... 
Printer Friendly Version
05/11/15OraSure Technologies to Present at the UBS Global Healthcare Conference 2015
BETHLEHEM, Pa., May 11, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference 2015 in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak May 18, 2015, at approximately 10:00 AM Eastern Time (7:00 AM Pacific Time). Interested investors can access the live webcast of the presentation by g... 
Printer Friendly Version